AnalystsStan BerenshteynStan Berenshteyn's Stock Forecasts
AnalystsStan Berenshteyn
Sectors:
Industries:
Analyst Ranking
Top 34%
#1548 out of 4554 analysts
Average Return
+1.45%
Win Rate
65%13 out of 20
Risk vs Reward
Poor
Good
Stan Berenshteyn's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Accolade IncACCD | +53.41% | $13.80 | $6.43 | 2022-04-10 - 2022-05-02 | Strong Sell |
Omnicell IncOMCL | +51.58% | $62.87 | $30.44 | 2023-07-19 - 2023-11-03 | Strong Sell |
Doximity IncDOCS | +35.25% | $26.47 | $35.80 | 2022-10-30 - 2023-05-01 | Strong Buy |
Omnicell IncOMCL | +33.22% | $45.58 | $30.44 | 2023-09-25 - 2023-11-03 | Strong Sell |
Healthequity IncHQY | +28.80% | $60.04 | $77.33 | 2023-02-02 - 2024-02-02 | Strong Buy |
Stan Berenshteyn Analyst Color
Get additional color on Stan Berenshteyn's coverage of popular stocks
Stan Berenshteyn's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Goodrx Holdings IncGDRX | 6 | Strong Buy | $10.00 | +48.59% | Upgrades | a month ago |
Omnicell IncOMCL | 9 | Hold | $26.00 | -4.59% | Maintains | 2 months ago |
Doximity IncDOCS | 6 | Hold | $27.00 | +8.78% | Maintains | 2 months ago |
Accolade IncACCD | 7 | Hold | $12.00 | +30.86% | Maintains | 3 months ago |
Healthequity IncHQY | 6 | Strong Buy | $93.00 | +16.47% | Maintains | 4 months ago |
Veeva Systems IncVEEV | 3 | Strong Buy | $229.00 | +14.76% | Upgrades | 6 months ago |
Health Catalyst IncHCAT | 3 | Strong Buy | $16.00 | N/A | Upgrades | a year ago |
Teladoc Health IncTDOC | 2 | Hold | $23.00 | N/A | Maintains | a year ago |
American Well CorpAMWL | 1 | Hold | $4.00 | N/A | Maintains | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.